Medifocus Guidebook On: Renal Cell Carcinoma
The MediFocus Guidebook on Renal Cell Carcinoma is the most comprehensive, up-to-date source of information available. You will get answers to your questions, including risk factors of Renal Cell Carcinoma, standard and alternative treatment options, leading doctors, hospitals and medical centers that specialize in Renal Cell Carcinoma, results of the latest clinical trials, support groups and additional resources, and promising new treatments on the horizon. This one of a kind Guidebook offers answers to your critical health questions including the latest treatments, clinical trials, and expert research; high quality, professional level information you can trust and understand culled from the latest peer-reviewed journals; and a unique resource to find leading experts, institutions, and support organizations including contact information and hyperlinks. This Guidebook was updated on February 2, 2012.
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
ablation Abstract Link advanced renal cell Anderson Cancer Center bevacizumab BJU Int Bukowski RM CAM therapies cancer patients cancer-related pain Chase Cancer Center chemotherapy Cleveland Clinic Cleveland Clinic Taussig Clin Oncol Clinic Taussig Cancer David Geffen Department of Medicine Department of Surgery Department of Urology drugs Epub Escudier Fox Chase Cancer Germany Glickman Urological Hematology Houston immunotherapy Institutional Affiliation Department interferon-alpha Italy firstname.lastname@example.org Journal kidney cancer Kidney Institute Laparoscopic M. D. Anderson Cancer Medical Center Medical Oncology Medical School Memorial Sloan-Kettering Cancer metastatic RCC metastatic renal cell Name of Author Oncology Department pain medications partial nephrectomy patients with metastatic radical nephrectomy renal cell cancer renal cell carcinoma Research Rini Royal Marsden Hospital School of Medicine side-effects Sloan-Kettering Cancer Center Solid Tumor Oncology sorafenib sunitinib targeted therapy Taussig Cancer Institute Texas M. D. Anderson treatment of metastatic tumor University Hospital University of Texas University School Urol Urologic Oncology Urological and Kidney